Related Experiment Video
Updated: Jul 17, 2025
Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
The Effectiveness of Ablation Therapy for Atrial Fibrillation: A Systematic Review
Arturo P Jaramillo1, Luisa Jaramillo2, Rebeca R Briones Andriuoli3
1General Medicine, Universidad Estatal de Guayaquil, Machala, ECU.
Insights
Atrial fibrillation (AF) ablation shows comparable outcomes to medical treatments, but more research is needed to determine the optimal AF treatment strategy for daily practice.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Research
Background:
- Atrial fibrillation (AF) is a prevalent cardiac arrhythmia, particularly in older adults (65-85), with increasing global prevalence expected by 2030.
- AF significantly impacts health-related quality of life, reducing patient activity levels and presenting diverse clinical symptoms, with women potentially experiencing more pronounced symptoms.
- Radiofrequency catheter ablation (CA) offers potential curative therapy for symptomatic AF, though long-term follow-up data are limited and referral patterns differ between genders, despite comparable outcomes.
Purpose of the Study:
- To provide an overview of the effectiveness of ablation therapy for atrial fibrillation (AF).
- To synthesize findings from existing literature comparing catheter ablation (CA) with pharmacological treatments for AF.
- To assess the efficacy of different CA techniques, including pulmonary vein isolation (PVI) with or without MRI-guided fibrosis ablation.
Main Methods:
- A systematic literature search was conducted using PubMed/Medline, Cochrane Library, and Google Scholar.
- Ten relevant publications were selected based on predefined qualifying criteria.
- The selected articles were analyzed to summarize the effectiveness of AF ablation therapy.
Main Results:
- Some studies indicated no statistically significant difference between invasive ablation and pharmacological treatments for AF.
- Research comparing pulmonary vein isolation (PVI) CA alone versus PVI with MRI-guided fibrosis ablation in persistent AF showed no difference in atrial arrhythmia recurrence.
- Studies involving elderly patients demonstrated no prognostic improvement with CA compared to medical treatment, with similarly low complication rates and efficacy across age groups.
Conclusions:
- Catheter ablation (CA) demonstrates comparable efficacy to medical treatments for atrial fibrillation (AF), with low complication rates across various age groups.
- Further research is essential to establish the most effective and evidence-based approach for treating AF in clinical practice.
- Optimizing AF treatment strategies requires continued investigation into long-term outcomes and comparative effectiveness of different therapeutic modalities.
Abstract:
It is expected that the prevalence of atrial fibrillation (AF), the most prevalent cardiac arrhythmia among people aged 65 to 85, would be mostly classified using the CHAS2DS2-VASc approach for anticoagulation therapy. A high number of people in the entire world will be living with AF by 2030. Long-term follow-up data are sparse, although radiofrequency catheter ablation (CA) for symptomatic AF patients has the potential to be a curative therapy. Although women are referred later and less often than men, the outcomes following ablation are comparable across both genders. Health-related quality of life suffers from AF, and patients often find themselves less active as a result of their condition. AF may have a wide variety of symptoms and signs from the clinic's point of view. Women are more likely to exhibit symptoms than men; one reason for this is that women have an average QT interval that is 10-20 milliseconds longer than men, which is more likely to exacerbate tachycardia symptoms. In search of medical databases for relevant medical literature, we looked at PubMed/Medline, the Cochrane Library, and Google Scholar. Ten publications were gathered after the papers were located, assessed, and qualifying criteria applied were used to select them. The finished articles were done to give an overview of the effectiveness of ablation therapy for AF. Some studies showed that there was no statistical significance between invasive and pharmacological treatments. Other research found no difference in the recurrence of atrial arrhythmia between pulmonary vein isolation (PVI) CA alone and PVI + enhancement magnetic resonance imaging (MRI)-guided fibrosis ablation in individuals with persistent AF. The oldest individuals in studies comparing CA to medical treatment for AF demonstrated no improvement in prognosis after CA. Also, complications from therapy and CA's efficacy in preventing future atrial arrhythmias were similarly low across all age groups. Based on the above, we concluded that more studies are required to establish the most effective approach to treating AF to apply it in daily practice and gain more knowledge about it.
Related Concept Videos
01:25Dysrhythmias VI: Management of Dysrhythmias
01:28Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...